BRPI0520221A2 - uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma - Google Patents

uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma

Info

Publication number
BRPI0520221A2
BRPI0520221A2 BRPI0520221-3A BRPI0520221A BRPI0520221A2 BR PI0520221 A2 BRPI0520221 A2 BR PI0520221A2 BR PI0520221 A BRPI0520221 A BR PI0520221A BR PI0520221 A2 BRPI0520221 A2 BR PI0520221A2
Authority
BR
Brazil
Prior art keywords
green tea
composition
nutrient composition
tea polyphenols
compound
Prior art date
Application number
BRPI0520221-3A
Other languages
English (en)
Inventor
Matthias Rath
Waheed M Roomi
Vadim Ivanov
Tatiana Kalinovsky
Aleksandra Niedzwiecki
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of BRPI0520221A2 publication Critical patent/BRPI0520221A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USO DE UMA COMPOSIÇçO NUTRIENTE QUE COMPREENDE POLIFENàIS DE CHÁ VERDE PARA TRATAMENTO DE OSTEOS SARCOMA. A presente invenção relaciona-se ao uso de uma composição que compreende um composto de ácido ascórbico, um composto de L-lisina, um composto de L-prolina e um composto de polifenol para a preparação de uma composição farmacêutica para tratamento de osteossarcoma. Além disso, a invenção também se relaciona a um método de tratamento em que a referida composição é administrada a um indivíduo que sofre de osteossarcoma.
BRPI0520221-3A 2005-04-11 2005-04-11 uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma BRPI0520221A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/003775 WO2006108430A1 (en) 2005-04-11 2005-04-11 Nutrient composition comprising green tea polyphenols for treating osteosarcoma

Publications (1)

Publication Number Publication Date
BRPI0520221A2 true BRPI0520221A2 (pt) 2009-04-22

Family

ID=35295399

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520221-3A BRPI0520221A2 (pt) 2005-04-11 2005-04-11 uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma

Country Status (3)

Country Link
EP (1) EP1874354A1 (pt)
BR (1) BRPI0520221A2 (pt)
WO (1) WO2006108430A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5696662B2 (ja) 2009-06-01 2015-04-08 日立化成株式会社 有機エレクトロルミネセンス素子、表示素子、照明装置および表示装置
US20160279043A1 (en) * 2013-03-18 2016-09-29 Dentalmed Pharm Holding Ltd. Combinations of n-acetyl cysteine derivatives and cranberry polyphenols in compositions and methods for preventing and treating periodontal diseases and peri-implatitis
WO2022124386A1 (en) * 2020-12-07 2022-06-16 L' Oreal Composition comprising ascorbic acid and cyclic amino acid
CN115836666B (zh) * 2021-09-20 2024-11-01 上海中医药大学附属龙华医院 原位骨肉瘤和肺转移瘤小鼠模型及其制法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198465A (en) * 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
WO2000057875A1 (en) * 1999-03-30 2000-10-05 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
PT1195159E (pt) * 2000-10-09 2006-08-31 Rath Matthias Combinacao terapeutica de ascorbato com lisina e arginina para prevencao e tratamento do cancro
PL215159B1 (pl) 2002-01-11 2013-10-31 Matthias Rath Odzywcza kompozycja farmaceutyczna uzyteczna w leczeniu raka oraz jej zastosowanie

Also Published As

Publication number Publication date
WO2006108430A8 (en) 2007-01-25
EP1874354A1 (en) 2008-01-09
WO2006108430A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
AR047928A1 (es) Derivados de tetrahidropiridoindol
BRPI0507198A (pt) derivados de bisariluréia
ATE382343T1 (de) Polyphenole enthaltende pharmazeutische nahrungsmittelergänzungsformel und ihre anwendung in der krebsbehandlung
ECSP088800A (es) Formulaciones de inhibidores de DPP IV
BR0315580A (pt) Derivados de metileno uréia
ECSP088288A (es) DERIVADOS DE 7-(2-AMINO-1-HIDROXI-ETIL)-4-HIDROXIBENZOTIAZOL-2(3H)-ONA COMO AGONISTAS DE LOS ADRENOCEPTORES ß2
CR20110270A (es) Piriloxi-indoles Inhibidores del VEGF-R2 y Uso de los Mismos para el Tratamiento de Enfermedades
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
MY160357A (en) Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
WO2005067489A3 (en) Type ii diabetes
UY31922A (es) Compuestos
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
CL2011000341A1 (es) Compuestos derivados de pirrolidinona sustituida, moduladores de la actividad de ar para la inhibicion de ntd; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de cancer, acne, hirsutismo, entre otras.
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
BRPI0515991A (pt) derivados de bisariluréia substituìda heterocìclica como inibidores de cinase
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
MX2010001693A (es) Composicion pulverizable que contiene extracto de hojas de parra rojas.
ECSP10010711A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
BRPI0520221A2 (pt) uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma
WO2010025335A3 (en) Functional consumable compositions for promoting skin health
TW200745133A (en) New compounds II

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.